Biotechnology and Artificial Intelligence: Integrating Technologies for Drug Discovery

The convergence of biotechnology and artificial intelligence (AI) is revolutionizing drug discovery and development. This article provides an extensive analysis of how these two fields are integrated, detailing the technologies involved, key applications, and the challenges faced. By harnessing the capabilities of biotechnology in understanding complex biological systems and the computational power of AI in handling big data, researchers have significantly accelerated the drug discovery process, offering new hope in the fight against various diseases. This article reviews the advancements, applications, challenges, and future potential of integrating biotechnology and AI in drug discovery, aiming to provide a comprehensive guide for researchers and industry professionals.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-14
DOI
https://doi.org/10.5281/zenodo.14160069
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biotechnology and Artificial Intelligence: Integrating Technologies for Drug Discovery

Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

Biotechnology and Artificial Intelligence: Integrating Technologies for Drug Discovery

article en

Abstract

The convergence of biotechnology and artificial intelligence (AI) is revolutionizing drug discovery and development. This article provides an extensive analysis of how these two fields are integrated, detailing the technologies involved, key applications, and the challenges faced. By harnessing the capabilities of biotechnology in understanding complex biological systems and the computational power of AI in handling big data, researchers have significantly accelerated the drug discovery process, offering new hope in the fight against various diseases. This article reviews the advancements, applications, challenges, and future potential of integrating biotechnology and AI in drug discovery, aiming to provide a comprehensive guide for researchers and industry professionals.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 54%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.